Drugs News and Research

RSS

Gov. Newsom wanted California to cut ties with Walgreens. Then federal law got in the way.

Gov. Gavin Newsom declared last month that California was "done" doing business with Walgreens after the pharmacy chain said it would not distribute an abortion pill in 21 states where Republicans threatened legal action. Since then, KHN has learned that the Democratic governor must compromise on his hard-line tweet.

6 Apr 2023

Revolution in MDR-TB treatment: Shorter all-oral regimens

Researchers reported on the evolution of multidrug-resistant tuberculosis (MDR-TB) therapy.

6 Apr 2023

Omicron BA.5 variant demonstrates increased neuroinvasiveness and pathogenicity in mice

Researchers assessed the extent of SARS-CoV-2 Omicron VOC BA.5 sub-VOC infection-associated brain infection and death.

5 Apr 2023

Promising new combination of drugs identified to treat juvenile myelomonocytic leukemia

Indiana University School of Medicine researchers have identified a promising new combination of drugs to treat juvenile myelomonocytic leukemia (JMML), a rare form of blood cancer that affects children.

5 Apr 2023

SFU researchers study pathogen genes to develop new drugs against bacterial infections

Researchers at Simon Fraser University are studying the genes of superbugs to aid the development of new and effective treatments for drug-resistant bacterial infections.

5 Apr 2023

St. Jude computational biologists characterize the full spectrum of oncogenic fusions in pediatric cancer

The scientific foundation needed to work on curing a class of cancer-causing mutations is here, in the form of a tool from St. Jude Children's Research Hospital.

5 Apr 2023

Researchers develop a method for making “mini-heart” using pluripotent stem cells

A team at the Technical University of Munich has induced stem cells to emulate the development of the human heart.

5 Apr 2023

New anticancer agent activated by ultrasound waves does not have strong side effects

Chemotherapy treatments produce strong side effects. A new agent that accumulates in the tumor tissue and is activated thereby ultrasound waves does not have this problem.

5 Apr 2023

Study: Alarming number of Canadian high school students smoke vapes containing nicotine

A new study by Jamie Seabrook of Brescia University College and Evan R. Wiley of Western University, has shown an alarming number of high school students – 26 per cent – in Canada reported having vaped in the previous month.

4 Apr 2023

Shape-shifting antibiotics may be the new weapon against drug-resistant superbugs

In the United States alone, drug-resistant bacteria and fungi infect almost 3 million people per year and kill about 35,000. Antibiotics are essential and effective, but in recent years overuse has led to some bacteria developing resistance to them.

4 Apr 2023

Promoting cellular recycling in the brain may reverse or prevent damage from traumatic brain injury

Each year about 1.5 million people in the U.S. survive a traumatic brain injury due to a fall, car accident, or a sports injury, which can cause immediate and long-term disability.

4 Apr 2023

Innovative approach to customize treatments for colorectal cancer

How to determine the most effective treatment for colon cancer? The response to chemotherapy varies greatly from one patient to another.

4 Apr 2023

UCSD engineers develop a biodegradable polymer system to treat rheumatoid arthritis

A team led by engineers at the University of California San Diego has developed a biodegradable polymer system to treat rheumatoid arthritis, an autoimmune and inflammatory disease, by working in concert with the power of the human immune system.

4 Apr 2023

MIP Discovery announces drugs of abuse reagent launch

MIP Discovery, a leader in rationally designed detection reagents based on its proprietary nanoMIP technology, in response to the growing synthetic opioid crisis has announced the launch of its first drugs of abuse products which are able to recognize norfentanyl, the main urinary metabolite of fentanyl.

From MIP Discovery 4 Apr 2023

Drugs News and Research

Gov. Newsom wanted California to cut ties with Walgreens. Then federal law got in the way.

Revolution in MDR-TB treatment: Shorter all-oral regimens

Omicron BA.5 variant demonstrates increased neuroinvasiveness and pathogenicity in mice

Promising new combination of drugs identified to treat juvenile myelomonocytic leukemia

SFU researchers study pathogen genes to develop new drugs against bacterial infections

St. Jude computational biologists characterize the full spectrum of oncogenic fusions in pediatric cancer

Researchers develop a method for making “mini-heart” using pluripotent stem cells

New anticancer agent activated by ultrasound waves does not have strong side effects

Study: Alarming number of Canadian high school students smoke vapes containing nicotine

Shape-shifting antibiotics may be the new weapon against drug-resistant superbugs

Promoting cellular recycling in the brain may reverse or prevent damage from traumatic brain injury

Innovative approach to customize treatments for colorectal cancer

UCSD engineers develop a biodegradable polymer system to treat rheumatoid arthritis

MIP Discovery announces drugs of abuse reagent launch

Is depression associated with gut mycobacteria dysbiosis in children?

Clinical trial findings may be a game changer in the treatment of pediatric Crohn's disease

Elucidating the function of BRCA2 gene offers insight into cancer development

Study elucidates the genetics of preterm birth and pregnancy length

Next-level technology for making time-released drugs could be a remedy for missed medications

Crystal engineering strategy could make medicines more soluble and palatable for children

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News